Press Releases Year None202220212020201920182017201620152014201320122011201020092008 Jan 4, 2022 Concert Pharmaceuticals Completes Enrollment in THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata Jan 3, 2022 Concert Pharmaceuticals to Present at H.C. Wainwright BIOCONNECT Virtual Conference
Jan 4, 2022 Concert Pharmaceuticals Completes Enrollment in THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata
